BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1051 related articles for article (PubMed ID: 30268158)

  • 1. The evaluation of changes in peripheral neuropathy and quality-of-life using low-frequency electrostimulation in patients treated with chemotherapy for breast cancer: a study protocol.
    Jang CE; Jung MS; Sohn EH; Kim M; Yoo HS; Bae K; Kim JR; Lee JS
    Trials; 2018 Sep; 19(1):526. PubMed ID: 30268158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized, Placebo-Controlled Trial Evaluating Changes in Peripheral Neuropathy and Quality of Life by Using Low-Frequency Electrostimulation on Breast Cancer Patients Treated With Chemotherapy.
    Song SY; Park JH; Lee JS; Kim JR; Sohn EH; Jung MS; Yoo HS
    Integr Cancer Ther; 2020; 19():1534735420925519. PubMed ID: 32493088
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and safety of auricular acupressure for chemotherapy-induced peripheral neuropathy among patients with breast cancer: a study protocol for a randomized controlled trial.
    Jung MS; Lee JS; Sohn EH; Cha K; Dlamini NS; Kim M
    Ann Palliat Med; 2021 Jan; 10(1):721-732. PubMed ID: 33440985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical study on concurrent use of electro-acupuncture or Chuna manual therapy with pregabalin for chemotherapy-induced peripheral neuropathy: safety and effectiveness (open-labeled, parallel, randomized controlled trial, assessor-blinded): A study protocol.
    Lee JH; Cho TJ; Park MG; Kim JH; Song SK; Park SY; Sunwoo YY; Lee I; Park TY
    Medicine (Baltimore); 2020 Jan; 99(3):e18830. PubMed ID: 32011497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the efficacy of an electronic symptom assessment and self-care intervention to preserve physical function in individuals receiving neurotoxic chemotherapy.
    Knoerl R; Weller E; Halpenny B; Berry D
    BMC Cancer; 2018 Dec; 18(1):1203. PubMed ID: 30514351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroacupuncture for chemotherapy-induced peripheral neuropathy: study protocol for a pilot multicentre randomized, patient-assessor-blinded, controlled trial.
    Kim JH; Kim EJ; Seo BK; Lee S; Lee S; Jung SY; Lee MH; Kim AR; Park HJ; Shin MS; Choi SM
    Trials; 2013 Aug; 14():254. PubMed ID: 23945074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601.
    Smith EM; Pang H; Ye C; Cirrincione C; Fleishman S; Paskett ED; Ahles T; Bressler LR; Le-Lindqwister N; Fadul CE; Loprinzi C; Shapiro CL;
    Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26603828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acupuncture and Reflexology for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer.
    Ben-Horin I; Kahan P; Ryvo L; Inbar M; Lev-Ari S; Geva R
    Integr Cancer Ther; 2017 Sep; 16(3):258-262. PubMed ID: 28150504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double blind, placebo controlled, phase II randomised cross-over trial investigating the use of duloxetine for the treatment of chemotherapy-induced peripheral neuropathy.
    Battaglini E; Park SB; Barnes EH; Goldstein D
    Contemp Clin Trials; 2018 Jul; 70():135-138. PubMed ID: 29680317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroacupuncture use for treatment of taxane-induced peripheral neuropathy in patients with breast cancer: protocol for a pilot, randomised, blinded, sham-controlled trial (EA for CIPN).
    Choi V; Park SB; Lacey J; Kumar S; Heller G; Grimison P
    BMJ Open; 2024 Jan; 14(1):e076391. PubMed ID: 38195173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy.
    Stubblefield MD; McNeely ML; Alfano CM; Mayer DK
    Cancer; 2012 Apr; 118(8 Suppl):2250-60. PubMed ID: 22488699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients.
    Bao T; Seidman AD; Piulson L; Vertosick E; Chen X; Vickers AJ; Blinder VS; Zhi WI; Li Q; Vahdat LT; Dickler MN; Robson ME; Mao JJ
    Eur J Cancer; 2018 Sep; 101():12-19. PubMed ID: 30007894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
    Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
    Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analgesic efficacy of pregabalin administered according to either a prevention protocol or an intervention protocol in rats with cisplatin-induced peripheral neuropathy.
    Han FY; Kuo A; Nicholson JR; Corradinni L; Smith MT
    Clin Exp Pharmacol Physiol; 2018 Oct; 45(10):1067-1075. PubMed ID: 29781509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing gait, balance, and muscle strength among breast cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): study protocol for a randomized controlled clinical trial.
    Teran-Wodzinski P; Haladay D; Vu T; Ji M; Coury J; Adams A; Schwab L; Visovsky C
    Trials; 2022 Apr; 23(1):363. PubMed ID: 35477489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.
    Kleckner IR; Kamen C; Gewandter JS; Mohile NA; Heckler CE; Culakova E; Fung C; Janelsins MC; Asare M; Lin PJ; Reddy PS; Giguere J; Berenberg J; Kesler SR; Mustian KM
    Support Care Cancer; 2018 Apr; 26(4):1019-1028. PubMed ID: 29243164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-induced peripheral neuropathy (CIPN) and its treatment: an NIH Collaboratory study of claims data.
    Gewandter JS; Kleckner AS; Marshall JH; Brown JS; Curtis LH; Bautista J; Dworkin RH; Kleckner IR; Kolb N; Mohile SG; Mustian KM
    Support Care Cancer; 2020 Jun; 28(6):2553-2562. PubMed ID: 31494735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reflexology in the management of chemotherapy induced peripheral neuropathy: A pilot randomized controlled trial.
    Kurt S; Can G
    Eur J Oncol Nurs; 2018 Feb; 32():12-19. PubMed ID: 29353627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial.
    Lu W; Giobbie-Hurder A; Freedman RA; Shin IH; Lin NU; Partridge AH; Rosenthal DS; Ligibel JA
    Oncologist; 2020 Apr; 25(4):310-318. PubMed ID: 32297442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of the online Acceptance and Commitment Therapy intervention "Embrace Pain" for cancer survivors with chronic painful chemotherapy-induced peripheral neuropathy: study protocol for a randomized controlled trial.
    van de Graaf DL; Mols F; Trompetter HR; van der Lee ML; Schreurs KMG; Børøsund E; Nes LS; Smeets T
    Trials; 2022 Aug; 23(1):642. PubMed ID: 35945582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.